Furthermore, treatment of SKBrM and 231BrM cells with CM generated from E2-treated microglia showed significant increase in their sphere forming ability (Fig. 3e) and CD44+/ESA+ cancer stem cell (CSC) population (Fig. 3f). The gene discussed is CD44; the disease is cancer.